Fundz

Hallux Inc. Announces Closing Of $9.4M Series A-2 Financing

PRIVATEApr 06, 2022

Amount Raised

$9.4 Million

Round Type

Series A

Laguna HillsHealthcare

Description

Hallux Inc., a clinical stage pharmaceutical company, today announced the initial closing of $9.4 million in its Series A-2 preferred stock financing round. Proceeds will be used for further clinical development of the company’s novel subungual approach for treating onychomycosis.

Quick answer

Hallux, Inc. raised $9.4 Million in a Series A round, dated April 6, 2022. Hallux, Inc. is based in Laguna Hills, California, United States.

How much did Hallux, Inc. raise?
Hallux, Inc. raised $9.4 Million in a Series A round on April 6, 2022.
What does Hallux, Inc. do?
Hallux is an innovative specialty pharmaceutical company focused on developing safe and highly effective breakthrough solutions for common infections of the toe, nail and foot.
Where is Hallux, Inc. based and how big is it?
Hallux, Inc. is based in Laguna Hills, California, United States.
Who are the decision-makers at Hallux, Inc?
Fundz holds 1 contact at Hallux, Inc. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as Hallux, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Renovo Concepts raised $420K on May 20, 2022.
  • Artelo Biosciences raised $97K (Pre-Seed) on May 20, 2022.
  • Klowen Braces raised $11M (Series A) on May 20, 2022.
  • Avstera Therapeutics raised $3.5M (Seed) on May 20, 2022.
  • Infectious Disease Connect raised $5.5M on May 20, 2022.
  • Acanna Therapeutics, Inc. raised $1M (Seed) on May 20, 2022.

Who to call at Hallux, Inc., and when

A new round usually means Hallux, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Hallux, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Hallux, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Hallux, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Hallux, Inc.

Location

Laguna Hills, California, United States

About

Hallux is an innovative specialty pharmaceutical company focused on developing safe and highly effective breakthrough solutions for common infections of the toe, nail and foot. The Company’s lead therapeutic candidate, Hallux Subungual Gel (HSG) is a novel terbinafine topical dosage form for treating toenail fungus, the most common nail disorder seen by podiatrists and dermatologists. HSG is designed for atraumatic physician administration direct to nail bed infection sites. The product will soon commence a Phase 2 efficacy, tolerability, and PK study in more moderately infected patients enrolled from OrthoArizona, a premier foot and ankle institute serving the greater Phoenix area. It is estimated that Podiatrists treat over 7 million patients a year for toenail fungus using routine nail debridement and Rx/OTC topicals, none of which work very well. The gold standard remains terbinafine tablets (Lamisil®) dosed daily for three months; however, topicals are widely preferred due to the oral’s risk of systemic side effects, especially liver toxicity. Hallux believes HSG could provide patients a cure rate exceeding oral terbinafine without systemic risk or the burden of daily pills for many months. Hallux is focused on achieving FDA and global registration of HSG and providing patients the highly effective topical therapy they have long sought to cure the ugly, embarrassing, and sometimes painful fungal infection that so many people around the world have had to live with for years.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Hallux, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts10 people are listed at Hallux, Inc.. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Hallux, Inc.'s next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Hallux, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.